BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22053820)

  • 1. Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD.
    Ohlmeier S; Mazur W; Linja-Aho A; Louhelainen N; Rönty M; Toljamo T; Bergmann U; Kinnula VL
    J Proteome Res; 2012 Feb; 11(2):599-608. PubMed ID: 22053820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease.
    Linja-aho A; Mazur W; Toljamo T; Nieminen P; Ohlmeier S; Rönty M; Kinnula VL
    APMIS; 2013 Jan; 121(1):11-21. PubMed ID: 23030783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
    Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL
    J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric immunoglobulin receptor down-regulation in chronic obstructive pulmonary disease. Persistence in the cultured epithelium and role of transforming growth factor-β.
    Gohy ST; Detry BR; Lecocq M; Bouzin C; Weynand BA; Amatngalim GD; Sibille YM; Pilette C
    Am J Respir Crit Care Med; 2014 Sep; 190(5):509-21. PubMed ID: 25078120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD.
    Kinnula VL; Ilumets H; Myllärniemi M; Sovijärvi A; Rytilä P
    Eur Respir J; 2007 Jan; 29(1):51-5. PubMed ID: 17050565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
    Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
    Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung tissue proteomics identifies elevated transglutaminase 2 levels in stable chronic obstructive pulmonary disease.
    Ohlmeier S; Nieminen P; Gao J; Kanerva T; Rönty M; Toljamo T; Bergmann U; Mazur W; Pulkkinen V
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1155-65. PubMed ID: 27084846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
    Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
    Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
    Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
    Chen H; Wang D; Bai C; Wang X
    J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma.
    Ishikawa N; Mazur W; Toljamo T; Vuopala K; Rönty M; Horimasu Y; Kohno N; Kinnula VL
    BMC Pulm Med; 2011 May; 11():22. PubMed ID: 21569324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects.
    Titz B; Sewer A; Schneider T; Elamin A; Martin F; Dijon S; Luettich K; Guedj E; Vuillaume G; Ivanov NV; Peck MJ; Chaudhary NI; Hoeng J; Peitsch MC
    J Proteomics; 2015 Oct; 128():306-20. PubMed ID: 26306861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein 27 and cyclophilin A associate with the pathogenesis of COPD.
    Hu R; Ouyang Q; Dai A; Tan S; Xiao Z; Tang C
    Respirology; 2011 Aug; 16(6):983-93. PubMed ID: 21585617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated sputum BPIFB1 levels in smokers with chronic obstructive pulmonary disease: a longitudinal study.
    Gao J; Ohlmeier S; Nieminen P; Toljamo T; Tiitinen S; Kanerva T; Bingle L; Araujo B; Rönty M; Höyhtyä M; Bingle CD; Mazur W; Pulkkinen V
    Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L17-26. PubMed ID: 25979078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids.
    Telenga ED; Hoffmann RF; Ruben t'Kindt ; Hoonhorst SJ; Willemse BW; van Oosterhout AJ; Heijink IH; van den Berge M; Jorge L; Sandra P; Postma DS; Sandra K; ten Hacken NH
    Am J Respir Crit Care Med; 2014 Jul; 190(2):155-64. PubMed ID: 24871890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated MMP-12 protein levels in induced sputum from patients with COPD.
    Demedts IK; Morel-Montero A; Lebecque S; Pacheco Y; Cataldo D; Joos GF; Pauwels RA; Brusselle GG
    Thorax; 2006 Mar; 61(3):196-201. PubMed ID: 16308335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients.
    Harju TH; Peltoniemi MJ; Rytilä PH; Soini Y; Salmenkivi KM; Board PG; Ruddock LW; Kinnula VL
    Respir Res; 2007 Jul; 8(1):48. PubMed ID: 17617905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis in lung tissue of smokers and COPD patients.
    Lee EJ; In KH; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; Yoo SH; Kim CH; Kim HK; Lee SH; Uhm CS
    Chest; 2009 Feb; 135(2):344-352. PubMed ID: 18753468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease.
    Kristan SS; Marc MM; Kern I; Flezar M; Suskovic S; Kosnik M; Korosec P
    Scand J Immunol; 2012 Jan; 75(1):109-14. PubMed ID: 21916917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.